IVD Firms Report Boom in Sales of COVID-19 Instruments, Tests

Fall-off in routine lab testing in second quarter was offset by robust sales of COVID-19 tests

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email
Because of the COVID-19 pandemic, second quarter earnings reports were a good news/bad news situation for most of the nation’s major in vitro diagnostic (IVD) companies. The good news was that demand for COVID-19 tests meant increased sales and revenues for IVD firms selling those products. But the collapse in routine lab testing that happened in March, April, May, and June was bad news …

IVD Firms Report Boom in Sales of COVID-19 Instruments, Tests Read More »

This post is only available to members.

Comments

;

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.